| UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| FORM 12b-25 |
| AMENDED |
| NOTIFICATION OF LATE FILING |
| (Check one): | ☐ Form 10-K | ☐ Form 20-F | ☐ Form 11-K | ☐ Form 10-Q | ☐ Form 10-D | ☐ Form N-CEN | ☐ Form N-CSR |
For Period Ended: December 31, 2021
| ☐ | Transition Report on Form 10-K | |
| ☐ | Transition Report on Form 20-F | |
| ☐ | Transition Report on Form 11-K | |
| ☐ | Transition Report on Form 10-Q |
| For the Transition Period Ended: |
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein .
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
| StHealth Capital Investment Corporation |
Full Name of Registrant
| First Capital Investment Corporation |
Former Name if Applicable
| 680 Fifth Avenue, 25th Floor |
Address of Principal Executive Office (Street and Number)
| New York, NY 10019 |
City, State and Zip Code
PART II - RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| ☒ | (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and; | |
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III - NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
This report on Form 12b-25 is an amendment to the Registrant’s Form 12b-25 filed with the Securities and Exchange Commission on April 6, 2022. With regard to one of the registrant’s significant portfolio company holdings, the registrant is awaiting the final valuation report for the subject portfolio company, in preparation by a third-party valuation group. Upon receipt of the final valuation report, then the registrant can: i) complete its valuation processes and procedures, ii) seek approval of the valuation process and conclusions from the registrant’s Board of Directors, iii) submit the valuation analysis and conclusions to the Registran’s independent auditor to complete the independent audit of the registrant’s financial statements; and then iv) expeditiously complete its Form 10-K.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
| Derek R. Taller | 212 | 601-2769 | ||
| (Name) | (Area Code) | (Telephone Number) |
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes ☒ No ☐
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes ☐ No ☒
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
| StHealth Capital Investment Corporation | ||
| (Name of Registrant as Specified in Charter) |
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
| Date 5/5/2022 | By: | /s/ Derek R. Taller |
| Chief Executive Officer | ||
